Your browser doesn't support javascript.
loading
Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial.
Weintraub, Daniel; Hauser, Robert A; Elm, Jordan J; Pagan, Fernando; Davis, Matthew D; Choudhry, Azhar.
Affiliation
  • Weintraub D; Departments of Psychiatry and Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Hauser RA; University of South Florida, Tampa, Florida, USA.
  • Elm JJ; Department of Public Health Science, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Pagan F; Georgetown University Medical Center, Washington, DC.
  • Davis MD; Teva Pharmaceuticals, West Chester, Pennsylvania, USA.
  • Choudhry A; Teva Pharmaceuticals, Overland Park, Kansas, USA.
Mov Disord ; 31(5): 709-14, 2016 05.
Article in En | MEDLINE | ID: mdl-27030249
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Dopamine Agents / Outcome Assessment, Health Care / Cognitive Dysfunction / Indans / Monoamine Oxidase Inhibitors Type of study: Clinical_trials / Etiology_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Mov Disord Journal subject: NEUROLOGIA Year: 2016 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Dopamine Agents / Outcome Assessment, Health Care / Cognitive Dysfunction / Indans / Monoamine Oxidase Inhibitors Type of study: Clinical_trials / Etiology_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Mov Disord Journal subject: NEUROLOGIA Year: 2016 Document type: Article Affiliation country: United States Country of publication: United States